Search Results - "Runglall, M."

Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment? by Rebollo‐Mesa, I., Nova‐Lamperti, E., Mobillo, P., Runglall, M., Christakoudi, S., Norris, S., Smallcombe, N., Kamra, Y., Hilton, R., Bhandari, S., Baker, R., Berglund, D., Carr, S., Game, D., Griffin, S., Kalra, P. A., Lewis, R., Mark, P. B., Marks, S., Macphee, I., McKane, W., Mohaupt, M. G., Pararajasingam, R., Kon, S. P., Serón, D., Sinha, M. D., Tucker, B., Viklický, O., Lechler, R. I., Lord, G. M., Hernandez‐Fuentes, M. P.

“…We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell–related genes and the…”
Get full text

Non-Invasive Tests to Help Stratify Risk of Rejection in Renal Transplant Recipients: Abstract# A25 by Runglall, M., Rebollo-Mesa, I., Mobillo, P., Kon, Phin S., Tucker, B., Farmer, C., Strom, T., Lord, G., Sacks, S., Hernandez-Fuentes, M., Chowdhury, P.

Get full text

Steroid Withdrawal Kidney Transplant Recipients Normalise Their Proportion of Transitional B Cells in Periphery, Contrary to the Absence of Change in Gene Expression: Abstract# A27 by Mobillo, P., Nova-Lamperti, E., Runglall, M., Rebollo-Mesa, I., Smallcombe, N., Duff, C., Lord, G., Hilton, R., Lechler, R., Hernandez-Fuentes, M.

Get full text

A Validated RT-PCR Based Gene Signature for Tolerance in Kidney Transplant Recipients: 1787 by Rebollo-Mesa, I., Norris, S., Nova-Lamperti, E., Mobillo, P., Runglall, M., Kamra, Y., Perucha, E., Lord, G., Lechler, R., Hernandez-Fuentes, M. P.

Get full text

A Validated RT-PCR Based Gene Signature for Tolerance in Kidney Transplant Recipients: 1787 by Rebollo-Mesa, I., Norris, S., Nova-Lamperti, E., Mobillo, P., Runglall, M., Kamra, Y., Perucha, E., Lord, G., Lechler, R., Hernandez-Fuentes, M. P.

Get full text

From Bench to Clinic: Translating Biomarkers of Tolerance in Renal Allograft Recipients: 1535 by Norris, S., Nova-Lamperti, E., Mobillo, P., Kamra, Y., Runglall, M., Rebollo-Mesa, I., Lord, G., Lechler, R., Hernandez-Fuentes, M.

Get full text

S1612 MOLECULAR MRD STATUS AND OUTCOME AFTER TRANSPLANTATION IN NPM1 MUTATED AML: RESULTS FROM THE UK NCRI AML17 STUDY by Dillon, R., Hills, R., Freeman, S., Potter, N., Jovanovic, J., Kanda, A., Runglall, M., Foot, N., Valganon, M., Raj, K., Khwaja, A., Cavenagh, J., Spearing, R., Ommen, H.B., Overgaard, U.M., Burnett, A., Russell, N., Grimwade, D.

“…Background: Relapse remains the primary cause of treatment failure for patients with acute myeloid leukaemia (AML) who undergo allogeneic stem cell…”
Get full text

Messenger RNA Levels in Peripheral Blood and Urine Can Potentially Stratify Risk of Rejection Following Renal Transplantation: 1583 by Runglall, M., Rebollo-Mesa, I., Mobillo, P., Norris, S., Kon, S. P., Tucker, B., Farmer, C. K.T., Lord, G., Strom, T., Sacks, S. H., Hernandez-Fuentes, M., Chowdhury, P.

Get full text